EP
MED icon

Essential Partners’s Medifast MED Stock Holding History

Essential Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$859 Sell
81
-553
-87% -$6.38K ﹤0.01% 2307
2026
Q1 		$6.46K Sell
634
-44
-6% -$474 ﹤0.01% 1465
2025
Q4 		$7.24K Sell
678
-926
-58% -$11.1K ﹤0.01% 1280
2025
Q3 		$21.9K Buy
1,604
+1,453
+962% +$20.3K 0.01% 863
2025
Q2 		$2.12K Buy
+151
New +$1.98K ﹤0.01% 1301

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Essential Partners's MED Position: Q2 2026 in Review

Essential Partners reduced its Medifast (MED) stake by 87% in Q2 2026, selling an estimated $6.38K and leaving 81 shares worth $859. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

Essential Partners first reported a position in MED in Q2 2025 and has held it in 5 quarters since. The position peaked at $21.9K in Q3 2025. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Essential Partners held 81 shares of Medifast worth $859 as of Q2 2026.
  • Essential Partners sold 553 Medifast shares in Q2 2026, an estimated $6.38K.
  • Medifast made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2307 holding.
  • Essential Partners first reported a position in Medifast in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Medifast position peaked at $21.9K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.